Submitted by Anonymous (not verified) on 1 February 2024 - 9:58
Orphan designation: Anagrelide hydrochloride monohydrate Treatment of gastrointestinal stromal tumours, 20/03/2023 Positive
Source:
Orphan designation: Anagrelide hydrochloride monohydrate Treatment of gastrointestinal stromal tumours, 20/03/2023 Positive